News Center
Lizhu Shining 2018 China Drug Formulation Conference
Release time:
2018-12-03
From November 30 to December 2, the "2018 12th China Drug Formulation Conference" hosted by the Chinese Pharmaceutical Association was held in Guangzhou. Wen Hong, the chief scientist of Livzon Group, attended the conference and delivered an important speech titled "Regulatory Considerations on the Consistency Evaluation of Different Drug Delivery Systems" at the Industrial Pharmacy Forum. Livzon Bei Yi (Injectable Acetate Leuprolide Microspheres) was awarded the 2018 Most Innovative Formulation Variety in China for its precise efficacy. The China Drug Formulation Conference is a platform to obtain cutting-edge research and development technology information in global drug formulation, grasp new dynamics in the field of drug formulation research, and promote communication and collaboration within the drug formulation industry.
From November 30 to December 2, the "2018 12th China Drug Formulation Conference" hosted by the Chinese Pharmaceutical Association was held in Guangzhou.
Wen Hong, Chief Scientist of Livzon Group, attended the conference and delivered an important speech titled "Regulatory Considerations on the Consistency Evaluation of Different Drug Delivery Systems" at the Industrial Pharmacy Forum.Livzon Beiyi (Injectable Acetate Leuprolide Microspheres) was awarded the 2018 Most Innovative Formulation Variety in China at the conference for its remarkable efficacy..
The China Drug Formulation Conference is a platform for obtaining cutting-edge research and development technology information in global drug formulation, grasping new dynamics in the field of drug formulation research, promoting communication and cooperation in the drug formulation industry, improving the level of pharmaceutical research in China, and advancing the scientific development of the pharmaceutical discipline.
This conference invited experts and scholars from the domestic and international pharmaceutical fields to discuss and analyze the healthy development of the drug formulation industry in the new era, and conducted extensive exchanges on new theories, new technologies, new achievements in pharmaceutical science, as well as their industrialization and clinical applications, jointly promoting the pharmaceutical field to a higher level and higher quality development.
Wen Hong, Chief Scientist of Livzon Group, delivered an important speech titled "Regulatory Considerations on the Consistency Evaluation of Different Drug Delivery Systems" at the Industrial Pharmacy Forum. Dr. Wen deeply analyzed the consistency evaluation requirements of different drug delivery systems for generic drugs at home and abroad from the aspects of pharmaceutical consistency and clinical efficacy consistency.
Livzon is a pharmaceutical company driven by research and development. It has established three national-level engineering research centers, including the National and Local Joint Engineering Research Center for Long-acting Microspheres. The microsphere center is dedicated to leading global sustained and controlled release drug delivery technology, developing longer-acting drugs to benefit patients. Livzon Beiyi (Injectable Acetate Leuprolide Microspheres) was awarded the 2018 Most Innovative Formulation Variety in China at this conference, which is a full recognition of Livzon's R&D efforts. It is believed that in the future, Livzon will make new contributions to the domestic research and development of sustained and controlled release drugs relying on the platform of the National and Local Joint Engineering Research Center for Long-acting Microspheres.
Related Information